Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD

Document Type

Article

Publication Date

2005

Abstract

Stimulant medication and behavioral treatments are evidence-based for children with attention-deficit/hyperactivity disorder, but the combination of the 2 treatments has been understudied. In this investigation, methylphenidate (MPH) was crossed with 2 levels of behavior modification (BMOD) in a summer treatment program. Twenty-seven children with attention-deficit/hyperactivity disorder, aged 6-12, participated. Children received placebo and 3 doses of transdermal MPH (12.5 cm2, 25.0 cm2, and 37.5 cm 2). BMOD was implemented on alternating weeks. Both treatments produced large and significant effects. Combined treatment was superior to either treatment alone. The effects of transdermal MPH were comparable to those found in this setting in previous studies with multiple stimulant medications and formulations. Consistent with other research, low doses of MPH-even lower than in previous studies-yielded enhanced effects in combination with behavior modification. Copyright 2005 by the American Psychological Association.

Publication Title

Experimental and clinical psychopharmacology

Volume

13

Issue

2

First Page

111

Last Page

126

Comments

This article was published in Experimental and clinical psychopharmacology, Volume 13, Issue 2, Pages 111-126.

The published version is available at http://dx.doi.org/10.1037/1064-1297.13.2.111.

Copyright © 2005 APA.

This document is currently not available here.

COinS